Results 81 to 90 of about 2,761,482 (311)

Ductal carcinoma in situ (DCIS) [PDF]

, 2013
Part 1 of this article may be found through this link: https://www.um.edu.mt/library/oar//handle/123456789/13825DCIS is rarely seen in US, where it may appear as a microlobulated mass with mild hypoechogenicity, ductal extension, and normal acoustic ...
Vassallo, Pierre
core   +1 more source

Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer

Advanced Science, EarlyView.
This study introduces a tumor‐targeted nanomicelle platform (preS1‐pHLIP) that exploits pre‐existing antiviral immunity to combat heterogeneous cancers. By delivering viral antigens to label tumors as virus‐like targets, the nanomicelles activate antiviral B and T cells, triggering in situ tumor lysis.
Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, Yuanqiang Li, Xinyang Ge, Tiefeng Jin, Gaofeng Hu, Zhuo Tan, Jiafeng Wang, Jiajie Xu, Liehao Jiang, Dan Wang, Zhangguo Ying, Xiao Zhao, Keman Cheng, Qinglin Li, Minghua Ge   +16 more
wiley   +1 more source

Carcinoma in situ of the bladder

Journal of British Surgery, 1971
Abstract Five cases of carcinoma in situ of the urinary bladder are reviewed. The clinical features, difficulties in diagnosis, and surgical management are discussed.
openaire   +3 more sources

BCG treatment of bladder cancer [PDF]

, 1990
The treatment of carcinoma in situ (CIS) occurring in isolation is even more problematic than that of multiple bladder tumours. Attempts have been made to control this condition by using instillations of commercially-available suspensions of BCG (Bacille
Busuttil, Anthony
core  

Structural validation of oral mucosal tissue using optical coherence tomography [PDF]

, 2012
Background: Optical coherence tomography (OCT) is a non-invasive optical technology using near-infrared light to produce cross-sectional tissue images with lateral resolution.
Al-Delayme, R, Hamdoon, Z, Hopper, C, Jay, A, Jerjes, W, McKenzie, G   +5 more
core   +1 more source

Targeting Replication Fork Processing Synergizes with PARP Inhibition to Potentiate Lethality in Homologous Recombination Proficient Ovarian Cancers

Advanced Science, EarlyView.
This study demonstrates that the resveratrol analogue, trans‐4,4′‐dihydroxystilbene (DHS), exhibits synergistic anti‐tumor activity with the PARP inhibitor talazoparib, inducing significant ovarian cancer cell death. The synergistic effect of this combination arises from the concurrent downregulation of homologous recombination factors and the ...
Ganesh Pai Bellare, Kshama Kundu, Papiya Dey, Krupa Thankam Philip, Nitish Chauhan, Muskan Sharma, Sankarsingh Kesharsingh Rajput, Birija Sankar Patro   +7 more
wiley   +1 more source

Predicting invasive breast cancer versus DCIS in different age groups. [PDF]

, 2014
BackgroundIncreasing focus on potentially unnecessary diagnosis and treatment of certain breast cancers prompted our investigation of whether clinical and mammographic features predictive of invasive breast cancer versus ductal carcinoma in situ (DCIS ...
Alagoz, Oguzhan, Ayvaci, Mehmet US, Burnside, Elizabeth S, Chhatwal, Jagpreet, Kerlikowske, Karla, Munoz del Rio, Alejandro, Nassif, Houssam, Sickles, Edward A   +7 more
core   +1 more source

Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells

Advanced Science, EarlyView.
Hypoxic and low‐glucose conditions in tumor tissues trigger colorectal tumor cell pyroptosis via sequential activation of the Caspase‐1/Caspase‐6/GSDMC axis. High mobility group box 1 (HMGB1), released from GSDMC‐mediated pyroptotic tumor cells, upregulates CXCL2 expression in adjacent tumor cells, thereby recruiting myeloid‐derived suppressor cells ...
Hanchao Gao, Yikun Yao, Weilong Li, Zigan Xu, Wenjun Hu, Kewang Luo, Peishan Chen, Wanjing Shang, Shaodong Luan, Guojun Shi, Mengtao Cao, Pengfei Chen   +11 more
wiley   +1 more source

Features of Pure Lobular Carcinoma In Situ on Magnetic Resonance Imaging Associated with Immediate Re-Excision after Lumpectomy

Journal of Breast Cancer, 2016
Purpose To evaluate imaging features of pure lobular carcinoma in situ (LCIS) on magnetic resonance imaging (MRI) in patients who underwent immediate re-excision after lumpectomy.
A. Chu, N. Cho, I. Park, S. Cho
semanticscholar   +1 more source

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS) [PDF]

, 2018
© 2018, Cancer Research UK. Background: Extracellular matrix (ECM) plays a crucial role in tumour behaviour. Prolyl-4-hydroxlase-A2 (P4HA2) is a key enzyme in ECM remodelling.
A Afghahi, A Boudreau, A Knopfelmacher, A Ringberg, A Unsworth, Abdulbaqi AlKawaz, AE Karnoub, Andrew R. Green, B Jarząb, C Curtis, D Hanahan, DM Gilkes, E Thompson, EA Rakha, Emad A. Rakha, Emma J. Groen, G Xiong, GD Leonard, GL Semenza, Hazem Khout, HJ Kim, Ian O. Ellis, Islam M. Miligy, J Condeelis, Johanna Myllyharju, K Mittal, K Raymond, KL Gorringe, KP Chang, KS McCarty Jr, Kylie L. Gorringe, LJ Solin, LM Coussens, M Allinen, M Hu, MD Allen, ME Feigin, ME Hammond, Michael S. Toss, Mina J Bissell, MJ Silverstein, MW Conklin, P Lu, PJ Keely, PP Provenzano, PP Provenzano, PW Pan, Q Shen, Radhakrishna Selvi, RL Camp, S Liu, Shona Hendry, W Wang, W Zhou, XJ Ma, Y Gong, Y Liu, Y Rattigan   +57 more
core   +2 more sources